TRDA - Entrada Therapeutics GAAP EPS of -$0.29 beats by $0.81 revenue of $41.85M March, 14 2024 02:56 AM Entrada Therapeutics Inc. 2024-03-14 02:56:20 ET More on Entrada Therapeutics Entrada Therapeutics promotes Dowden to President Seeking Alpha’s Quant Rating on Entrada Therapeutics Historical earnings data for Entrada Therapeutics Financial information for Entrada Therapeutics For further details see: Entrada Therapeutics GAAP EPS of -$0.29 beats by $0.81, revenue of $41.85M